Guidance Archives - Page 45 of 637

1 minute read

Ryan Specialty Sees Organic Revenue Growth Rate Guidance For Full Year 2024 Is Between 12.5%–14%

May 2, 4:23 PM

Full Year 2024 Outlook*The Company is maintaining its full year 2024 outlook for Organic Revenue Growth Rate (under the legacy calculation methodology) and Adjusted EBITDAC Margin. The full year 2024 outlook (under

RYAN

1 minute read

Verra Mobility Sees FY24 EPS $1.15-$1.20 Vs $1.18 Est.; Revenue $865M-$880M Vs $872.63M Est.

By Benzinga Newsdesk

May 2, 4:21 PM

2024 Full Year GuidanceAny guidance that we provide is subject to change as a variety of factors can affect actual operating results. Certain of the factors that may impact our actual operating results are identified

VRRM

1 minute read

Paylocity Sees Q4 Revenue $347.8M-$351.8M Vs $345.72M Est.; FY24 Revenue $1.393B-$1.397B Vs $1.39B Est.

By Benzinga Newsdesk

May 2, 4:16 PM

Business OutlookBased on information available as of May 2, 2024, Paylocity is issuing guidance for the fourth quarter and full fiscal year 2024 as indicated below.Fourth Quarter 2024:Total revenue is expected to be

PCTY

2 minute read

Digital Realty Trust Maintains Its 2024 Core FFO Per Share And Constant-Currency Core FFO Per Share Outlook Of $6.60-$6.75

By Benzinga Newsdesk

May 2, 4:15 PM

2024 OutlookDigital Realty maintained its 2024 Core FFO per share and Constant-Currency Core FFO per share outlook of $6.60 - $6.75. The assumptions underlying the outlook are summarized in the following

DLR

1 minute read

Motorola Solutions Sees Q2 EPS $2.97-$3.02 Vs $2.91 Est.; Revenue Growth Between 7%-8% Vs Last Year; Raises FY24 EPS From $12.62-$12.72 To $12.98-$13.08 Vs $12.74 Est.; Raises Revenue Growth From 6% To 7% Vs Last Year

By Benzinga Newsdesk

May 2, 4:13 PM

BUSINESS OUTLOOKSecond quarter 2024 - The company expects revenue growth between 7% and 8% compared to the second quarter of 2023. The company expects non-GAAP EPS in the range of $2.97 to $3.02 per share. This assumes

MSI

2 minute read

Eye Disease-Focused Glaukos’ ‘Investor Interest Should Continue To Gain Momentum:’ Analyst

By Vandana Singh

May 2, 3:36 PM

Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.

GKOS

2 minute read

Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?

By Vandana Singh

May 2, 3:12 PM

Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis.

BAX

1 minute read

Dominion Energy Reports Mixed Bag Of Q1 Earnings, Sticks To Annual Guidance

By Lekha Gupta

May 2, 2:15 PM

Dominion Energy reported Q1 FY24 revenue of $3.632B, missing consensus of $4.380B. Adjusted EPS was $0.55 and company reaffirms FY24 and FY25 guidance.

BKGI